Table 1 Characteristics of participants by BMI categories
From: Associations between body mass index and the risk of renal events in patients with type 2 diabetes
Overall (n = 10,537) | Normal weight (n = 2894) | Overweight (n = 4340) | Obesity grade 1 (n = 2265) | Obesity grade 2 (n = 744) | Obesity grade 3 (n = 294) | |
|---|---|---|---|---|---|---|
Male sex, n (%) | 6063 (57.5) | 1658 (57.3) | 2687 (61.9) | 1255 (55.4) | 358 (48.1) | 105 (35.7) |
Asia, n (%) | 3988 (37.8) | 1998 (69.1) | 1661 (38.3) | 291 (12.8) | 33 (4.4) | 5 (1.7) |
Established market economies, n (%) | 4537 (43.1) | 681 (23.5) | 1896 (43.7) | 1279 (56.5) | 483 (64.9) | 198 (67.3) |
Eastern Europe, n (%) | 2012 (19.1) | 215 (7.4) | 783 (18.0) | 695 (30.7) | 228 (30.7) | 91 (31.0) |
Age (years): mean (SD) | 65.8 (6.4) | 65.9 (6.3) | 66.2 (6.4) | 65.8 (6.4) | 64.2 (6.2) | 63.4 (5.9) |
Body mass index (kg/m2): mean (SD) | 28.3 (5.1) | 23.0 (1.5) | 27.4 (1.4) | 32.0 (1.4) | 37.0 (1.4) | 44.4 (5.0) |
Systolic blood pressure (mmHg): mean (SD) | 145 (21) | 141 (22) | 146 (21) | 148 (21) | 148 (21) | 146 (20) |
Diastolic blood pressure (mmHg): mean (SD) | 81 (11) | 78 (11) | 81 (11) | 82 (11) | 83 (11) | 82 (11) |
Use of antihypertensive treatment, n (%) | 7237 (68.9) | 1675 (57.9) | 3014 (69.5) | 1710 (75.5) | 590 (79.3) | 248 (84.4) |
Duration of diabetes (years): mean (SD) | 7.9 (6.3) | 9.1 (6.9) | 7.6 (6.1) | 7.4 (6.2) | 6.8 (5.8) | 7.0 (5.7) |
HbA1C (%): mean (SD) | 7.5 (1.5) | 7.6 (1.8) | 7.4 (1.4) | 7.5 (1.4) | 7.5 (1.4) | 7.6 (1.6) |
HbA1C (mmol/mol): mean (SD) | 58 (17) | 60 (19) | 57 (16) | 58 (16) | 59 (16) | 60 (17) |
eGFR (ml/min/1.73 m2): mean (SD) | 75 (17) | 76 (20) | 75 (17) | 73 (17) | 74 (17) | 74 (17) |
Urinary ACR (mg/g): median (Q1, Q3) | 15 (7, 40) | 16 (8, 43) | 15 (7, 38) | 14 (6, 38) | 13 (7, 36) | 17 (7, 41) |
Serum Total cholesterol (mmol/l): mean (SD) | 5.2 (1.2) | 5.2 (1.2) | 5.2 (1.2) | 5.2 (1.2) | 5.2 (1.1) | 5.3 (1.1) |
Serum LDL cholesterol (mmol/l): mean (SD) | 3.1 (1.0) | 3.1 (1.0) | 3.1 (1.0) | 3.1 (1.0) | 3.1 (1.0) | 3.2 (1.1) |
Serum HDL cholesterol (mmol/l): mean (SD) | 1.3 (0.3) | 1.3 (0.4) | 1.2 (0.3) | 1.2 (0.3) | 1.2 (0.3) | 1.2 (0.3) |
Serum triglycerides (mmol/l) | 1.6 (1.2, 2.3) | 1.4 (1.0, 2.1) | 1.6 (1.2, 2.3) | 1.8 (1.3, 2.5) | 1.8 (1.4, 2.5) | 2.0 (1.4, 2.7) |
Use of lipid lowering drugs, n (%) | 3674 (34.9) | 700 (24.2) | 1609 (37.1) | 910 (40.2) | 328 (44.1) | 127 (43.2) |
History of current smoking, n (%) | 1579 (15.0) | 448 (15.5) | 644 (14.8) | 307 (13.6) | 132 (17.7) | 48 (16.3) |
History of ever smoking, n (%) | 4415 (41.9) | 941 (32.5) | 1859 (42.8) | 1080 (47.7) | 400 (53.8) | 135 (45.9) |
Prior cardiovascular disease, n (%) | 2725 (25.9) | 700 (24.2) | 1194 (27.5) | 571 (25.2) | 194 (26.1) | 66 (22.5) |
